UniDoc Successfully Concludes Pilot Trials with OnPharm-United

Vancouver, British Columbia, CANADA

--OnPharm-United requests to move project to contract

VANCOUVER, British Columbia, Aug. 31, 2022 (GLOBE NEWSWIRE) -- UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce it has successfully concluded a series of pilot trials with OnPharm-United, a network of independent pharmacies in Canada.

As previously announced (March 9, 2022), pursuant to a letter of intent (the “LOI”) of October 8, 2021, UniDoc and OnPharm-United agreed to jointly offer a health care and virtual care platform solution exclusively to the entire OnPharm-United network in Ontario subject to the successful testing of UniDoc’s Virtual Care Solutions Model. These tests have now concluded satisfactorily and OnPharm-United has indicated it is ready to progress to contract UniDoc’s services including development of roll-out details, locations, and timelines to its network of pharmacies throughout Ontario.

Dr. Chad Burkhart, UniDoc’s Telemedicine advisor, states: “The OnPharm-United pilot tests were a resounding success. As an active professional participant in the test, not only was I able to undertake patient visits remotely, but I was also able to easily use the available diagnostic tools and was further able to process and transact the standard rate services fees with OHIP for the visit. In my mind, this validates our entire process from both the patient and the provider prospective.”

OnPharm-United was founded by independent pharmacy owners, for independent pharmacy owners. The board members and executives of the organization operate independent pharmacies and understand the needs, challenges, and opportunities of their over 600 independent pharmacy members across Ontario.

As part of the proposed service contract, UniDoc intends to enter into a business agreement with OnPharm-United as soon as commercially possible, the details of which will be announced upon execution of the proposed contract. UniDoc, as part of the LOI has agreed to provide a variety of equipment and installation supervision, software installation and training services.

UniDoc CEO Antonio Baldassarre comments, “Today’s announcement is a significant achievement for everyone involved with our growing venture. Acceptance by OnPharm-United is an important validation of our concept and launches us directly into an important segment of the domestic healthcare sector. We are extremely pleased that the test was a success and look forward to working with the OnPharm-United team to finalize the next steps and advance our transition from a domestic development phase into active operations in one of the busiest marketplaces in Canada.”

On Behalf of the Board of Directors,


~Antonio Baldassarre~

Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.

About OnPharm-United
OnPharm-United was created by OnPharm Inc. and United Pharma Group in October 2018 by bringing together two of the fastest growing networks for independent pharmacies in Canada. OnPharm-United includes over 600 members in Ontario. OnPharm-United provides its members with the ability to maintain their independent status while benefiting from a suite of innovative programs, services and resources to support their business and practice. For more information visit: www.onpharmunited.ca.

About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)
UniDoc is developing a telehealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. Telehealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress. You are also invited to join us on social media with Facebook, Twitter or Instagram.

For further information, please contact
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com

Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com

Media Inquiries

Forward-Looking Statements

This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, the entry into a service contract with OnPharm-United and the terms thereof, the provision by UniDoc of equipment and installation supervision, software installation and training services to OnPharm-United and the transition of the Company from a domestic development phase into active operations.

Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s final prospectus dated December 2, 2021 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.